These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 22296034

  • 1. NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes.
    Gong ZC, Huang Q, Dai XP, Lei GH, Lu HB, Yin JY, Xu XJ, Qu J, Pei Q, Dong M, Zhou BT, Shen J, Zhou G, Zhou HH, Liu ZQ.
    Br J Clin Pharmacol; 2012 Sep; 74(3):501-9. PubMed ID: 22296034
    [Abstract] [Full Text] [Related]

  • 2. Effects of NOS1AP rs12742393 polymorphism on repaglinide response in Chinese patients with type 2 diabetes mellitus.
    Wang T, Wang Y, Lv DM, Song JF, Lu Q, Gao X, Zhang F, Guo H, Li W, Yin XX.
    Pharmacotherapy; 2014 Feb; 34(2):131-9. PubMed ID: 24338736
    [Abstract] [Full Text] [Related]

  • 3. NAMPT -3186C/T polymorphism affects repaglinide response in Chinese patients with Type 2 diabetes mellitus.
    Sheng FF, Dai XP, Qu J, Lei GH, Lu HB, Wu J, Xu XJ, Pei Q, Dong M, Liu YZ, Zhou HH, Liu ZQ.
    Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):550-4. PubMed ID: 21631570
    [Abstract] [Full Text] [Related]

  • 4. IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population.
    Huang Q, Yin JY, Dai XP, Pei Q, Dong M, Zhou ZG, Huang X, Yu M, Zhou HH, Liu ZQ.
    Acta Pharmacol Sin; 2010 Jun; 31(6):709-17. PubMed ID: 20523342
    [Abstract] [Full Text] [Related]

  • 5. Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients.
    Huang Q, Yin JY, Dai XP, Wu J, Chen X, Deng CS, Yu M, Gong ZC, Zhou HH, Liu ZQ.
    Eur J Clin Pharmacol; 2010 Dec; 66(12):1207-15. PubMed ID: 20809084
    [Abstract] [Full Text] [Related]

  • 6. Effects of UCP2 -866 G/A and ADRB3 Trp64Arg on rosiglitazone response in Chinese patients with Type 2 diabetes.
    Yang M, Huang Q, Wu J, Yin JY, Sun H, Liu HL, Zhou HH, Liu ZQ.
    Br J Clin Pharmacol; 2009 Jul; 68(1):14-22. PubMed ID: 19659999
    [Abstract] [Full Text] [Related]

  • 7. PPARD rs2016520 polymorphism affects repaglinide response in Chinese Han patients with type 2 diabetes mellitus.
    Song JF, Wang T, Zhu J, Zhou XY, Lu Q, Guo H, Zhang F, Wang Y, Li W, Wang DD, Cui YW, Lv DM, Yin XX.
    Clin Exp Pharmacol Physiol; 2015 Jan; 42(1):27-32. PubMed ID: 25311380
    [Abstract] [Full Text] [Related]

  • 8. Effect of genetic polymorphism of UCP2-866 G/A on repaglinide response in Chinese patients with type 2 diabetes.
    Wang S, Se YM, Liu ZQ, Lei MX, Hao-BoYang, Sun ZX, Nie SD, Zeng XM, Wu J.
    Pharmazie; 2012 Jan; 67(1):74-9. PubMed ID: 22393835
    [Abstract] [Full Text] [Related]

  • 9. KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) polymorphisms affect therapeutic efficacy of repaglinide in Chinese patients with type 2 diabetes.
    Yu M, Xu XJ, Yin JY, Wu J, Chen X, Gong ZC, Ren HY, Huang Q, Sheng FF, Zhou HH, Liu ZQ.
    Clin Pharmacol Ther; 2010 Mar; 87(3):330-5. PubMed ID: 20054294
    [Abstract] [Full Text] [Related]

  • 10. A variant of GRK5 is associated with the therapeutic efficacy of repaglinide in Chinese Han patients with type 2 diabetes mellitus.
    Shang Z, Han F, Zhou X, Bao Z, Zhu J, Wang T, Lu Q, Du L, Li W, Lv D, Yin X.
    Drug Dev Res; 2018 May; 79(3):129-135. PubMed ID: 29663513
    [Abstract] [Full Text] [Related]

  • 11. A Variation in the ABCC8 Gene Is Associated with Type 2 Diabetes Mellitus and Repaglinide Efficacy in Chinese Type 2 Diabetes Mellitus Patients.
    Zhou X, Chen C, Yin D, Zhao F, Bao Z, Zhao Y, Wang X, Li W, Wang T, Jin Y, Lv D, Lu Q, Yin X.
    Intern Med; 2019 Aug 15; 58(16):2341-2347. PubMed ID: 31118371
    [Abstract] [Full Text] [Related]

  • 12. KCNQ1 gene polymorphisms are associated with the therapeutic efficacy of repaglinide in Chinese type 2 diabetic patients.
    Dai XP, Huang Q, Yin JY, Guo Y, Gong ZC, Lei MX, Jiang TJ, Zhou HH, Liu ZQ.
    Clin Exp Pharmacol Physiol; 2012 May 15; 39(5):462-8. PubMed ID: 22414228
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of variant A45T in NEUROD1/BETA2 for its association with type 2 diabetes mellitus.
    Han X, Xiao J, Ren Q, Tang Y, Yang W, Ji L.
    Endocrine; 2013 Aug 15; 44(1):99-106. PubMed ID: 23203005
    [Abstract] [Full Text] [Related]

  • 14. The association of adiponectin allele 45T/G and -11377C/G polymorphisms with Type 2 diabetes and rosiglitazone response in Chinese patients.
    Sun H, Gong ZC, Yin JY, Liu HL, Liu YZ, Guo ZW, Zhou HH, Wu J, Liu ZQ.
    Br J Clin Pharmacol; 2008 Jun 15; 65(6):917-26. PubMed ID: 18429970
    [Abstract] [Full Text] [Related]

  • 15. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS, Tarnow L, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag AA.
    Eur J Endocrinol; 2008 Jan 15; 158(1):35-46. PubMed ID: 18166815
    [Abstract] [Full Text] [Related]

  • 16. Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes.
    Liu HL, Lin YG, Wu J, Sun H, Gong ZC, Hu PC, Yin JY, Zhang W, Wang D, Zhou HH, Liu ZQ.
    Eur J Clin Pharmacol; 2008 Jul 15; 64(7):663-71. PubMed ID: 18438653
    [Abstract] [Full Text] [Related]

  • 17. Beta-cell dysfunction in late-onset diabetic subjects carrying homozygous mutation in transcription factors NeuroD1 and Pax4.
    Kanatsuka A, Tokuyama Y, Nozaki O, Matsui K, Egashira T.
    Metabolism; 2002 Sep 15; 51(9):1161-5. PubMed ID: 12200761
    [Abstract] [Full Text] [Related]

  • 18. Association of PAX4 genetic variants with oral antidiabetic drugs efficacy in Chinese type 2 diabetes patients.
    Chen M, Hu C, Zhang R, Jiang F, Wang J, Peng D, Tang S, Sun X, Yan J, Luo Y, Bao Y, Jia W.
    Pharmacogenomics J; 2014 Oct 15; 14(5):488-92. PubMed ID: 24752311
    [Abstract] [Full Text] [Related]

  • 19. Impact of retinol binding protein 4 polymorphism on rosiglitazone response in Chinese type 2 diabetic patients.
    Zhou F, Huang Q, Dai X, Yin J, Wu J, Zhou H, Gong Z, Liu Z.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Oct 15; 36(10):949-57. PubMed ID: 22086013
    [Abstract] [Full Text] [Related]

  • 20. Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients.
    He YY, Zhang R, Shao XY, Hu C, Wang CR, Lu JX, Bao YQ, Jia WP, Xiang KS.
    Acta Pharmacol Sin; 2008 Aug 15; 29(8):983-9. PubMed ID: 18664331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.